BCLI Brainstorm Cell Therapeutics
- 0.639
- +0.019+3.11%
Brainstorm Cell Therapeutics News
Brainstorm Cell Therapeutics | 10-Q: Quarterly report
Brainstorm Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lebovits Chaim
Brainstorm Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lebovits Chaim
Brainstorm Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lebovits Chaim
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lebovits Chaim
Brainstorm Cell Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Dagher Ibrahim B.
Brainstorm Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lebovits Chaim
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 424B5: Prospectus
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 10-K: Annual report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lindborg Stacy
Brainstorm Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yablonka Uri
Brainstorm Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Patlis Alla
Brainstorm Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lebovits Chaim
Brainstorm Cell Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kevin D. Ness(6.25%)
Analysis
Price Target
No Data
